Literature DB >> 21677057

Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction.

Elise Dalmas1, Christine Rouault, Meriem Abdennour, Carole Rovere, Salwa Rizkalla, Avner Bar-Hen, Jean-Louis Nahon, Jean-Luc Bouillot, Michèle Guerre-Millo, Karine Clément, Christine Poitou.   

Abstract

BACKGROUND: Obesity is considered a low-grade inflammatory state that improves with weight loss. In addition to acute-phase proteins, other cytokines might contribute to systemic inflammation.
OBJECTIVE: Our objective was to compare serum concentrations of a large panel of inflammation-related factors in obese and normal-weight subjects and to determine kinetic changes induced by caloric restriction.
DESIGN: The cohort comprised 14 normal-weight women and 51 obese women who were followed over 2 y after Roux-en-Y gastric bypass. Multiplexed proteomics were used to simultaneously assay 27 cytokines and growth factors in serum.
RESULTS: Concentrations of interleukin (IL)-9, IL-1-receptor antagonist, IL-10, interferon-γ-inducible protein 10, macrophage inflammatory protein 1β, monocyte chemoattractant protein 1, IL-8, RANTES (regulated upon activation, normal T cell expressed and secreted), monokine induced by interferon-γ, and vascular endothelial growth factor were found to be elevated in obesity. IL-10 was further elevated in diabetic obese patients, whereas eotaxin was found to be higher only in diabetic subjects. After surgery, many factors showed a biphasic pattern of variation, decreasing sharply at month 3 before rising back to presurgical values at month 6; these changes closely tracked similar kinetic changes in calorie and carbohydrate intake. After 1 y, an overall reduction in cytokines accompanied the reduction in body mass index and an amelioration in metabolic status.
CONCLUSIONS: Obesity is associated with elevated circulating concentrations of a large panel of cytokines. Coordinated kinetic changes during weight loss suggest an early influence of calorie and carbohydrate intakes, whereas a longer-term reduction in corpulence might prevail in regulating circulating cytokine concentrations. This trial is registered at clincaltrials.gov as NCT00476658.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21677057     DOI: 10.3945/ajcn.111.013771

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  42 in total

Review 1.  T Cell Populations and Functions Are Altered in Human Obesity and Type 2 Diabetes.

Authors:  Sothea Touch; Karine Clément; Sébastien André
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

2.  Obesity promotes prolonged ovalbumin-induced airway inflammation modulating T helper type 1 (Th1), Th2 and Th17 immune responses in BALB/c mice.

Authors:  F M C Silva; E E Oliveira; A C C Gouveia; A S S Brugiolo; C C Alves; J O A Correa; J Gameiro; J Mattes; H C Teixeira; A P Ferreira
Journal:  Clin Exp Immunol       Date:  2017-03-31       Impact factor: 4.330

3.  Changes in intestinal permeability after Roux-en-Y gastric bypass.

Authors:  Alexandre Lages Savassi-Rocha; Marco Túlio Costa Diniz; Eduardo Garcia Vilela; Maria de Fátima Haueisen Sander Diniz; Soraya Rodrigues de Almeida Sanches; Aloísio Sales da Cunha; Maria de Lourdes de Abreu Ferrari; Henrique Oswaldo da Gama Torres; Bruno Antonio Maciente; Gabriela Santana Ataliba; Paloma Maciel Araújo; Taciana Bretas Guerra; Inara Kellen Fonseca Balbino
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

4.  Effects of sleeve gastrectomy in high fat diet-induced obese mice: respective role of reduced caloric intake, white adipose tissue inflammation and changes in adipose tissue and ectopic fat depots.

Authors:  Anne-Sophie Schneck; Antonio Iannelli; Stéphanie Patouraux; Déborah Rousseau; Stéphanie Bonnafous; Beatrice Bailly-Maitre; Ophélia Le Thuc; Carole Rovere; Patricia Panaia-Ferrari; Rodolphe Anty; Albert Tran; Philippe Gual; Jean Gugenheim
Journal:  Surg Endosc       Date:  2013-10-03       Impact factor: 4.584

Review 5.  Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?

Authors:  Jean Debédat; Chloé Amouyal; Judith Aron-Wisnewsky; Karine Clément
Journal:  Semin Immunopathol       Date:  2019-04-25       Impact factor: 9.623

Review 6.  The importance of the gut microbiota after bariatric surgery.

Authors:  Judith Aron-Wisnewsky; Joel Doré; Karine Clement
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-08-28       Impact factor: 46.802

7.  Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

Authors:  Isabelle Magalhaes; Karine Pingris; Christine Poitou; Stéphanie Bessoles; Nicolas Venteclef; Badr Kiaf; Lucie Beaudoin; Jennifer Da Silva; Omran Allatif; Jamie Rossjohn; Lars Kjer-Nielsen; James McCluskey; Séverine Ledoux; Laurent Genser; Adriana Torcivia; Claire Soudais; Olivier Lantz; Christian Boitard; Judith Aron-Wisnewsky; Etienne Larger; Karine Clément; Agnès Lehuen
Journal:  J Clin Invest       Date:  2015-03-09       Impact factor: 14.808

8.  Probiotic Supplementation in Morbid Obese Patients Undergoing One Anastomosis Gastric Bypass-Mini Gastric Bypass (OAGB-MGB) Surgery: a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.

Authors:  Zohreh Karbaschian; Zeinab Mokhtari; Abdolreza Pazouki; Ali Kabir; Mahdi Hedayati; Somayeh Soleymanzadeh Moghadam; Parvin Mirmiran; Azita Hekmatdoost
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

9.  SMRT-GPS2 corepressor pathway dysregulation coincides with obesity-linked adipocyte inflammation.

Authors:  Amine Toubal; Karine Clément; Rongrong Fan; Patricia Ancel; Veronique Pelloux; Christine Rouault; Nicolas Veyrie; Agnes Hartemann; Eckardt Treuter; Nicolas Venteclef
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

Review 10.  The impact of bariatric surgery on inflammation: quenching the fire of obesity?

Authors:  Samar Hafida; Tooraj Mirshahi; Barbara S Nikolajczyk
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-10       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.